Usa covid-19 death Usa

Pfizer to allow more nations to make COVID drug, files for EUA with FDA

Reading now: 654
www.cidrap.umn.edu

Pfizer today announced that it has signed a voluntary licensing agreement to expand production of its new COVID-19 treatment, Paxlovid, for low- and middle-income countries, which follows a similar announcement from Merck for molnupiravir.Also today, Pfizer announced that it has applied for emergency use authorization from the US Food and Drug Administration (FDA) for Paxlovid.

The Biden administration plans to buy 10 million treatment courses of the Pfizer drug, sources told NBC News.Deal would ease access for 95 countriesIn its licensing announcement, Pfizer said it signed an agreement with the Medicines Patent Pool (MPP), a United Nations-based group, enabling MPP to boost international production by granting sublicenses to generic

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA